A Phase I Study of the Safety and Pharmacokinetics of the Combination of Pertuzumab (rhuMab 2C4) and Capecitabine in Patients with Advanced Solid Tumors
Albanell, J., Montagut, C., Jones, E. T., Pronk, L., Mellado, B., Beech, J., Gascon, P., Zugmaier, G., Brewster, M., Saunders, M. P., Valle, J. W.Volume:
14
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-07-1980
Date:
May, 2008
File:
PDF, 175 KB
english, 2008